Zovirax

Zovirax Special Precautions

aciclovir

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Full Prescribing Info
Special Precautions
Dispersible tab/Oral susp: Hydration status: Care should be taken to maintain adequate hydration in patients receiving high oral doses of aciclovir.
Powd for inj: In patients receiving ZOVIRAX IV for infusion at higher doses (e.g. for herpes encephalitis), specific care regarding renal function should be taken, particularly when patients are dehydrated or have any renal impairment.
Reconstituted ZOVIRAX IV for infusion has a pH of approximately 11.0 and should not be administered by mouth.
Effects on Ability to Drive and Use Machines: There have been no studies to investigate the effect of aciclovir on driving performance or the ability to operate machinery.
Dispersible tab/Oral susp: The clinical status of the patient and the adverse event profile of ZOVIRAX should be borne in mind when considering the patient's ability to drive or operate machinery.
Further, a detrimental effect on such activities cannot be predicted from the pharmacology of the active substance.
Powd for inj: ZOVIRAX IV for infusion is generally used in an in-patient hospital population and information on ability to drive and operate machinery is not usually relevant.
In patients receiving ZOVIRAX IV for infusion at higher doses (e.g. for herpes encephalitis), specific care regarding renal function should be taken, particularly when patients are dehydrated or have any renal impairment.
Reconstituted ZOVIRAX IV for infusion has a pH of approximately 11.0 and should not be administered by mouth.
Use in patients with renal impairment and in elderly patients: Aciclovir is eliminated by renal clearance, therefore the dose must be reduced in patients with renal impairment (see Dosage & Administration). Elderly patients are likely to have reduced renal function and therefore the need for dose reduction must be considered in this group of patients. Both elderly patients and patients with renal impairment are at increased risk of developing neurological side effects and should be closely monitored for evidence of these effects. In the reported cases, these reactions were generally reversible on discontinuation of treatment (see Adverse Reactions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in